Application of Tongxinluo in preparing medicament for treating pulmonary hypertension
A technology for treating pulmonary hypertension and drugs, applied in drug combinations, pharmaceutical formulas, plant raw materials, etc., to achieve the effects of treating pulmonary hypertension, improving remodeling, and reducing pulmonary vascular resistance
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Publication Date
- 2013-03-20
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
Technical field:
[0001] The invention relates to the field of medicinal chemistry, in particular to the new application of Tongxinluo drug, especially the application of Tongxinluo in the preparation of drug for treating pulmonary hypertension. Background technique:
[0002] Tongxinluo Capsule (Chinese Pharmacopoeia 2005 Edition Part One - Page 586) is a traditional Chinese medicine compound capsule developed by using the theory of collateral diseases in traditional Chinese medicine, under the guidance of the treatment methods of nourishing qi, promoting blood circulation and removing blood stasis, searching wind, relieving spasm and dredging collaterals. The main ingredients are leech, scorpion, centipede, cicada slough, and wood beetle, which are made of five kinds of insect medicines, together with ginseng, red peony root, borneol, sandalwood, balsamic incense, frankincense (made), jujube seed (stir-fried) and other medicines. It has the effects of nourishing qi and activ...
Examples
Embodiment 1
[0011] 1. Materials and methods
[0012] 1.1 Establishment of Rat Pulmonary Hypertension Model
[0013] Male SPF grade SD rats, weighing 200-220g. One-time subcutaneous injection of monocrotaline (Monocrotaline, MCT, 40mg / kg), 3 weeks later, right heart catheterization was used randomly to measure pulmonary artery pressure and hemodynamic parameters to identify whether the model was successfully established.
[0014] 1.2 Experimental grouping and drug intervention
[0015] (1) Model group (MCT group): 10 rats were given normal saline by intragastric administration after the pulmonary hypertension model was successfully established for 3 consecutive weeks.
[0016] (2) Tongxinluo low-dose group (Tongxinluo 0.2g·kg·d group): 10 rats were given Tongxinluo by intragastric administration after the pulmonary hypertension model was successfully established for 3 consecutive weeks.
[0017] (3) Tongxinluo middle-dose group (Tongxinluo 0.4g·kg·d group): 10 rats were given Tongxinluo...